Stella Pharma Corporation announced a private placement of 4th stock acquisition rights on December 14, 2022. The transaction will include participation from SMBC Nikko Securities Inc.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
347 JPY | +0.87% | +13.91% | +20.70% |
13/02 | Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 | CI |
2023 | Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+20.70% | 6.94Cr | |
+31.37% | 60TCr | |
-2.60% | 37TCr | |
+20.83% | 33TCr | |
+5.69% | 29TCr | |
+14.83% | 24TCr | |
+9.93% | 21TCr | |
-6.95% | 20TCr | |
+10.77% | 17TCr | |
+0.10% | 16TCr |
- Stock Market
- Equities
- 4888 Stock
- News Stella Pharma Corporation
- Stella Pharma Corporation announced that it expects to receive funding from SMBC Nikko Securities Inc.